Alimta and bone marrow failure Patient Reports February 12, 2012



Alimta Side Effects Report #4865589-7
Alimta side effect was reported by a Physician from FRANCE on Dec 13, 2005. Male patient, 76 years of age, weighting 145.5 lb, was diagnosed with pleural mesothelioma malignant and was treated with Alimta. After drug was administered, patient experienced the following side effects: bone marrow failure, mucosal inflammation, pyrexia. Alimta dosage: 900 MG OTHER INTRAVENOUS. During the same period patient was treated with CISPLATIN. Patient recovered.

Alimta Side Effects Report #4928175-6
Alimta side effect was reported by a Physician from FRANCE on Feb 08, 2006. Male patient, 76 years of age, weighting 145.5 lb, was diagnosed with pleural mesothelioma malignant and was treated with Alimta. After drug was administered, patient experienced the following side effects: bone marrow failure, disease progression, mucosal inflammation, pyrexia. Alimta dosage: 900 MG, OTHER INTRAVENOUS. During the same period patient was treated with CISPLATIN, FOLIC ACID, VITAMIN B12. Patient recovered.

Alimta Side Effects Report #5386646-5
Alimta side effect was reported by a Physician from ITALY on July 06, 2007. Female patient, 72 years of age, was diagnosed with pleural mesothelioma malignant, antiemetic supportive care and was treated with Alimta. After drug was administered, patient experienced the following side effects: bone marrow failure, dysphagia, electrolyte imbalance, lip oedema, pyrexia, renal failure, stomatitis. Alimta dosage: 700 MG, OTHER. During the same period patient was treated with CISPLATIN, FOLIC ACID, VITAMIN B, DELTACORTENE, NAVOBAN, INTRAFER. Patient was hospitalized. Patient died on 06/13/2007.

Alimta Side Effects Report #5725025-5
Alimta side effect was reported by a Physician from AUSTRALIA on Apr 23, 2008. Male patient, 54 years of age, was diagnosed with pleural mesothelioma malignant and was treated with Alimta. After drug was administered, patient experienced the following side effects: bone marrow failure, neutropenic colitis. Alimta dosage: unknown. During the same period patient was treated with CARBOPLATIN, VITAMINS. Patient was hospitalized. Patient recovered.


Alimta Side Effects Report #5766883-8
Alimta side effect was reported by a Physician from AUSTRALIA on June 02, 2008. Male patient, 54 years of age, was diagnosed with pleural mesothelioma malignant and was treated with Alimta. After drug was administered, patient experienced the following side effects: bone marrow failure, neutropenic colitis. Alimta dosage: unknown. During the same period patient was treated with CARBOPLATIN, VITAMINS, VITAMIN B, FOLIC ACID. Patient was hospitalized. Patient recovered.

Alimta Side Effects Report #5772227-8
Alimta side effect was reported by a Physician from AUSTRALIA on June 02, 2008. Male patient, 54 years of age, was diagnosed with pleural mesothelioma malignant and was treated with Alimta. After drug was administered, patient experienced the following side effects: bone marrow failure, neutropenic colitis. Alimta dosage: unknown. During the same period patient was treated with CARBOPLATIN, VITAMINS, VITAMIN B, FOLIC ACID. Patient was hospitalized. Patient recovered.

Alimta Side Effects Report #5735870-8
Alimta side effect was reported by a Physician from UNITED STATES on May 02, 2008. Male patient was diagnosed with pleural mesothelioma malignant and was treated with Alimta. After drug was administered, patient experienced the following side effects: bone marrow failure, unresponsive to stimuli. Alimta dosage: 500 MG, UNK. During the same period patient was treated with CARBOPLATIN. Patient recovered.

Alimta Side Effects Report #5378785-X
Alimta side effect was reported by a Physician from ITALY on June 25, 2007. Female patient, 72 years of age, was diagnosed with pleural mesothelioma, antiemetic supportive care and was treated with Alimta. After drug was administered, patient experienced the following side effects: bone marrow failure, dysphagia, lip oedema, mucosal inflammation, pancytopenia, pyrexia. Alimta dosage: 700 MG, OTHER. During the same period patient was treated with CISPLATIN, FOLIC ACID, VITAMIN B, DELTACORTENE, NAVOBAN, INTRAFER. Patient was hospitalized. Patient died on 06/13/2007.

Alimta Side Effects Report #5440453-3
Alimta side effect was reported by a Physician from UNITED STATES on Aug 27, 2007. Male patient was diagnosed with non-small cell lung cancer stage iv, vitamin supplementation and was treated with Alimta. After drug was administered, patient experienced the following side effects: blood count abnormal, bone marrow failure, mucosal inflammation, renal failure. Alimta dosage: 500 MG, UNK. During the same period patient was treated with VITAMIN B, FOLIC ACID, CORTICOSTEROID NOS. Patient was hospitalized. Patient died on 06/26/2007.


Alimta Side Effects Report #4791672-0
Alimta side effect was reported by a Physician from FRANCE on Sept 19, 2005. Male patient, 70 years of age, was diagnosed with non-small cell lung cancer metastatic and was treated with Alimta. After drug was administered, patient experienced the following side effects: bone marrow failure, catheter site infection, pancytopenia, pseudomonas infection, septic shock, staphylococcal infection What is  staphylococcal infection. Alimta dosage: 500 MG/M2 1 OTHER. During the same period patient was treated with FOLIC ACID, VITAMIN B, DEXAMETHASONE. Patient was hospitalized. Patient died on 09/14/2005.

Alimta Side Effects Report #4900994-1
Alimta side effect was reported by a Physician from FRANCE on Jan 23, 2006. Male patient, 71 years of age, weighting 145.5 lb, was diagnosed with non-small cell lung cancer and was treated with Alimta. After drug was administered, patient experienced the following side effects: bone marrow failure, c-reactive protein increased, catheter related infection, multi-organ failure, neutropenia, pseudomonal sepsis, septic shock, staphylococcal sepsis. Alimta dosage: 500 MG/M2, OTHER, INTRAVENOUS. During the same period patient was treated with FOLIC ACID, VITAMIN B12, DEXAMETHASONE, NEULASTA, DIGOXINE, CREON, NEURONTIN. Patient was hospitalized. Patient died on 09/14/2005.

Alimta Side Effects Report #4910391-0
Alimta side effect was reported by a Physician from FRANCE on Jan 23, 2006. Male patient, 71 years of age, weighting 145.5 lb, was diagnosed with non-small cell lung cancer and was treated with Alimta. After drug was administered, patient experienced the following side effects: acute respiratory distress syndrome, bone marrow failure, dialysis What is  dialysis, multi-organ failure, pseudomonal sepsis, renal failure acute, septic shock, staphylococcal sepsis. Alimta dosage: 500 MG/M2 INTRAVENOUS. During the same period patient was treated with FOLIC ACID, VITAMIN B12, DEXAMETHASONE PHOSPHATE, NEULASTA, DIGOXIN, CREON, NEURONTIN. Patient was hospitalized. Patient died on 08/14/2005.

Alimta Side Effects Report #5319982-9
Alimta side effect was reported by a Physician from FRANCE on May 03, 2007. Female patient, 66 years of age, was diagnosed with non-small cell lung cancer, vitamin supplementation, prophylaxis and was treated with Alimta. After drug was administered, patient experienced the following side effects: bone marrow failure, renal failure, septic shock. Alimta dosage: unknown. During the same period patient was treated with FOLIC ACID, VITAMIN B, CORTICOSTEROID NOS. Patient was hospitalized. Patient died on 04/30/2007.

Alimta Side Effects Report #5427437-6
Alimta side effect was reported by a Physician from FRANCE on Aug 17, 2007. Male patient, 65 years of age, was diagnosed with non-small cell lung cancer and was treated with Alimta. After drug was administered, patient experienced the following side effects: bone marrow failure, gastrointestinal haemorrhage. Alimta dosage: unknown. Patient was hospitalized. Patient died on 08/05/2007.


Alimta Side Effects Report #5145332-7
Alimta side effect was reported by a Physician from UNITED STATES on Oct 20, 2006. Male patient, 60 years of age, weighting 166.0 lb, was diagnosed with non-small cell lung cancer, pain What is  pain, vitamin supplementation and was treated with Alimta. After drug was administered, patient experienced the following side effects: bone marrow failure, malaise, renal failure. Alimta dosage: unknown. During the same period patient was treated with PERCOCET, FOLIC ACID, VITAMIN B. Patient was hospitalized. Patient died on 10/27/2006.

Alimta Side Effects Report #5723167-1
Alimta side effect was reported by a Physician from FRANCE on Apr 21, 2008. Male patient, 55 years of age, weighting 154.3 lb, was diagnosed with non-small cell lung cancer, vitamin supplementation, prophylaxis, metastases to bone, pain What is  pain and was treated with Alimta. After drug was administered, patient experienced the following side effects: bone marrow failure, eczema What is  eczema, mucosal inflammation, pyrexia, staphylococcal sepsis. Alimta dosage: 500 MG/M2, OTHER. During the same period patient was treated with FOLIC ACID, VITAMIN B, CORTICOSTEROID NOS, ZOMETA, DURAGESIC, ZOPHREN. Patient was hospitalized. Patient died on 02/24/2008.

Alimta Side Effects Report #4930139-3
Alimta side effect was reported by a Consumer or non-health professional from FRANCE on Feb 06, 2006. Female patient, 32 years of age, was diagnosed with non-small cell lung cancer and was treated with Alimta. After drug was administered, patient experienced the following side effects: bone marrow failure, pericarditis, septic shock, small intestinal obstruction. Alimta dosage: unknown. During the same period patient was treated with GEMZAR, CISPLATIN, TARCEVA. Patient recovered.

Alimta Side Effects Report #5339543-5
Alimta side effect was reported by a Physician from UNITED STATES on Jan 24, 2007. Female patient was diagnosed with non-small cell lung cancer and was treated with Alimta. After drug was administered, patient experienced the following side effects: bone marrow failure. Alimta dosage: 500 MG/M2. Patient recovered.

Alimta Side Effects Report #5608068-1
Alimta side effect was reported by a Health Professional from UNITED STATES on Jan 28, 2008. Male patient, 61 years of age, weighting 95.50 lb, was diagnosed with neoplasm malignant and was treated with Alimta. After drug was administered, patient experienced the following side effects: bone marrow failure, dehydration, dyspnoea, metabolic acidosis, renal failure acute, sepsis What is  sepsis. Alimta dosage: unknown. During the same period patient was treated with OXALIPLATIN. Patient died on 01/25/2008.


Alimta Side Effects Report #5616371-4
Alimta side effect was reported by a Consumer or non-health professional from UNITED STATES on Feb 05, 2008. Male patient, weighting 185.0 lb, was diagnosed with metastasis, non-small cell lung cancer and was treated with Alimta. After drug was administered, patient experienced the following side effects: anorexia, asthenia, blood pressure decreased, bone marrow failure, chills, clostridial infection, confusional state, dialysis What is  dialysis, diarrhoea. Alimta dosage: unknown. Patient was hospitalized. Patient died on 12/31/2007.

Alimta Side Effects Report #5620324-X
Alimta side effect was reported by a Physician from ITALY on Jan 29, 2008. Female patient was diagnosed with mesothelioma malignant recurrent and was treated with Alimta. After drug was administered, patient experienced the following side effects: bone marrow failure, catheter sepsis, haematotoxicity, shock haemorrhagic. Alimta dosage: 750 MG, PER CYCLE. During the same period patient was treated with FOLIC ACID, VITAMIN B. Patient was hospitalized. Patient died on 01/22/2008.

Alimta Side Effects Report #5914931-4
Alimta side effect was reported by a Physician from ITALY on Oct 02, 2008. Female patient was diagnosed with mesothelioma malignant recurrent and was treated with Alimta. After drug was administered, patient experienced the following side effects: bone marrow failure, catheter sepsis, circulatory collapse, haematotoxicity, shock haemorrhagic. Alimta dosage: 750 MG, PER CYCLE. During the same period patient was treated with FOLIC ACID, VITAMIN B. Patient was hospitalized. Patient died on 01/22/2008.

Alimta Side Effects Report #5675316-1
Alimta side effect was reported by a Physician from UNITED STATES on Aug 06, 2007. Male patient was diagnosed with mesothelioma What is  mesothelioma and was treated with Alimta. After drug was administered, patient experienced the following side effects: bone marrow failure. Alimta dosage: 500 MG/M2,OTHER. During the same period patient was treated with GEMZAR. Patient recovered.

Alimta Side Effects Report #6055669-5
Alimta side effect was reported by a Physician from FRANCE on Jan 20, 2009. Female patient, 59 years of age, weighting 152.1 lb, was diagnosed with lung adenocarcinoma, vitamin supplementation, prophylaxis, vomiting, metastases to bone, constipation What is  constipation and was treated with Alimta. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood alkaline phosphatase increased, bone marrow failure, erysipelas, febrile bone marrow aplasia, gamma-glutamyltransferase increased. Alimta dosage: unknown. During the same period patient was treated with FOLIC ACID, VITAMIN B, PREDNISONE, EMEND, METHYLPREDNISOLONE, ZOPHREN, LYTOS, DUPHALAC. Patient was hospitalized. Patient recovered.


Alimta Side Effects Report #4850756-9
Alimta side effect was reported by a Physician from FRANCE on Nov 24, 2005. Male patient, 76 years of age, was treated with Alimta. After drug was administered, patient experienced the following side effects: bone marrow failure, mucosal inflammation, pyrexia. Alimta dosage: 900 MG, OTHER, INTRAVENOUS. Patient recovered.
SideEffects101.com does not provide medical advice, diagnosis or treatment. The material on this site is for informational purposes only, and is not a substitute for medical advice, diagnosis or treatment provided by a qualified health care provider. Thank you for visiting SideEffects101.com and reading about

side effects of Alimta